Vigilant Biosciences
PrivateLast Round
VC Round
Nov 1, 2019
Est. Valuation
$7.8M
Total Funding Raised
$13.02M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Vigilant Biosciences is a healthcare company that develops and provides solutions for the early detection of oral and oropharyngeal cancer.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotechnology, Medical AI, Precision Medicine
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Vigilant Biosciences Comparables
Compare Vigilant Biosciences with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| CURO Biosciences Private Limited | 82% | |
| Forward Science | 82% | |
| OrisDX | 79% | |
Vigilant Biosciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Nov 1, 2019 | ||||
| Grant | Aug 11, 2016 | ||||
| Series B Extension | Jul 11, 2016 | ||||
| Series B | Feb 24, 2015 | ||||
| Series A | Mar 25, 2014 |
Vigilant Biosciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Institute for Commercialization of Florida Technology | Series B |
| venVelo | Series B, Series B Extension |
| National Institute of Dental and Craniofacial Research | Grant |
| Novalis LifeSciences | VC Round |
| White Owl Capital Partners | Series B, Series B Extension |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 12, 2026
Monthly visitors increased 44% MoM.
- Mar 2, 2026
Monthly visitors grew 860% MoM, from 119 to 1.1K.
Vigilant Biosciences Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Vigilant Biosciences's valuation, stock price, and market status.